Otto Licks comenta sobre lei de Propriedade Industrial

September 8, 2021

This content is available on

Estadão

A reportagem "Lei que permite quebra de patente de vacina não deve gerar tanto impacto, dizem especialistas", do jornal "ESTADÃO", ouviu nosso sócio Otto Licks, que afirmou que o licenciamento compulsório de vacinas e medicamentos deve ser tratado como exceção. "A regra é o governo trabalhar com a iniciativa privada para chegar a melhores soluções, como a Fiocruz fez com a AstraZeneca, o Butantan com a Sinovac e, agora, a Pfizer com a Eurofarma", disse Otto. Saiba mais em: https://bit.ly/3BIwxRx

-

Newspaper O Estado de S. Paulo published the article "Specialists say that law for breaching of vaccine patents won't have a huge impact” interviewed our founding partner Otto Licks, where he stated that compulsory licensing of vaccines and medicines must be treated as an exception. “As a rule, the government works alongside the private sector to reach the best solutions, such was the case for Fiocruz and AstraZenecas, Butantan and Sinovac, and recently, Pfizer and Eurofarma”. More at: https://bit.ly/3BIwxRx

Previous Post

There is no previous post

Back to all posts

Next Post

There is no next post

Back to all posts

RECENT PUBLICATIONS

LINKEDIN FEED

Newsletter

Register your email and receive our updates

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FOLLOW US ON SOCIAL MEDIA

Newsletter

Register your email and receive our updates-

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FOLLOW US ON SOCIAL MEDIA